Experience of Using Central Venous Catheter Broviaс in Pediatric Oncological Practice

V.L. Kobys, O.M. Kliusov, S.P. Zavertylenko


 The article describes the clinical experience of using central venous catheter (CVC) Broviac in 80 children with cancer. It is shown that the risk of catheter-associated bloodstream infection (CABI) is 1.1 per 1,000 catheter-days, which is compared to the data in developed countries. We have analyzed complications when using catheter, worked out the technique of managing patients with CABI.
These data show the safety and feasibility of using CVC Broviaс in children with cancer.


Cantrell M., Ruble K. Multidisciplinary care in pediatric onco­logy // J. Multidiscip. Healthc. — 2011. — Vol. 4. — P. 171-181.

Freyer D., Felgenhauer J., Perentesis J. Children’s Oncology Group’s 2013 Blueprint for Research: Adolescent and Young Adult Oncology // Pediatr. Blood Cancer. — 2013. — Vol. 60, № 6. — P. 1055-1058.

Рыков М.Ю., Гьокова Е.В., Поляков В.Г. Профилактика катетер-ассоциированных инфекций кровотока в онкопедиатрии // Journal Malignant Tumors. — 2013. — Vol. 2. — P. 71-81.

Galloway S., Bodenham A. Long-term central venous access // British Journal of Anaesthesia. — 2004. — Vol. 92, № 5. — P. 722-734.

Mermel L., Allon M., Bouza E. et al. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America // Clin. Infect. Dis. — 2009. — Vol. 49, № 1. — P. 1-45.

Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2018


   Seo анализ сайта